Goldman Sachs Group Inc Milestone Pharmaceuticals Inc. Put Options Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MIST
# of Institutions
43Shares Held
30.2MCall Options Held
32.8KPut Options Held
0-
Black Rock Inc. New York, NY4.97MShares$7.21 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$4.72 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$3.99 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$3.85 Million1.58% of portfolio
-
Lion Point Capital, LP New York, NY2.34MShares$3.39 Million6.61% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $43.5M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...